The miR-30 family inhibits pulmonary vascular hyperpermeability in the premetastatic phase by direct targeting of Skp2

Clinical Cancer Research

Volumn 21, Issue 13, 2015, Pages 3071-3080

  Qi, Feifei ^a,b   He, Ting ^a,b   Jia, Lin ^a,b   Song, Nan ^a,b   Guo, Lifang ^a,b   Ma, Xuhui ^a,b   Wang, Chunying ^a,b   Xu, Min ^a,b   Fu, Yan ^a,b   Li, Lin ^a,b   Luo, Yongzhang ^a,b  

^a TSINGHUA UNIVERSITY   (China)

^b Beijing Key Laboratory for Protein Therapeutics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; LENTIVIRUS VECTOR; MATRIX METALLOPROTEINASE 14; MICRORNA; MICRORNA 30; MICRORNA 30A; MICRORNA 30B; MICRORNA 30C; MICRORNA 30D; MICRORNA 30E; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL UNTRANSLATED RNA; STROMELYSIN; STROMELYSIN 2; SUPPRESSOR OF CYTOKINE SIGNALING 1; UNCLASSIFIED DRUG; MIRN30D MICRORNA, MOUSE; S PHASE KINASE ASSOCIATED PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE THERAPY; KLF9 GENE; LUNG METASTASIS; METASTASIS INHIBITION; MICROARRAY ANALYSIS; MMP10 GENE; MMP14 GENE; MMP2 GENE; MMP3 GENE; MMP9 GENE; MOLECULARLY TARGETED THERAPY; MOUSE; NEDD4L GENE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULMONARY VASCULAR DISEASE; PULMONARY VASCULAR HYPERPERMEABILITY; RAB38 GENE; REAL TIME POLYMERASE CHAIN REACTION; SKP2 GENE; SNAI1 GENE; SOCS1 GENE; SURVIVAL TIME; UBE2I GENE; UGT8A GENE; VASCULAR REMODELING; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CAPILLARY PERMEABILITY; EXPERIMENTAL MELANOMA; GENETICS; HEK293 CELL LINE; HUMAN; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; SECONDARY; VASCULARIZATION;

3T3 CELLS; ANIMALS; CAPILLARY PERMEABILITY; FEMALE; HEK293 CELLS; HUMANS; LUNG; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICRORNAS; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 84942163774     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-2785     Document Type: Article

References (41)

1. Sethi N, Kang Y. Unravelling the complexity of metastasis-molecular understanding and targeted therapies. Nat Rev Cancer 2011;11:735-48.
2. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820-7.
3. Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009;9:285-93.
4. Hiratsuka S, Watanabe A, Aburatani H, Maru Y. Tumour-mediated upre-gulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat Cell Biol 2006;8:1369-75.
5. Huang Y, Song N, Ding Y, Yuan S, Li X, Cai H, et al. Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis. Cancer Res 2009;69:7529-37.
6. Hiratsuka S, Ishibashi S, Tomita T, Watanabe A, Akashi-Takamura S, Murakami M, et al. Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci. Nat Commun 2013;4:1853.
7. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007;446:765-70.
8. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, et al. TGFbeta primes breast tumors for lung metastasis seeding through angio-poietin-like 4. Cell 2008;133:66-77.
9. Yan HH, Pickup M, Pang Y, Gorska AE, Li Z, Chytil A, et al. Gr-1+CD11b+ myeloid cells tip the balance ofimmune protectiontotumor promotion in the premetastatic lung. Cancer Res 2010;70:6139-49.
10. Minami T, Jiang S, Schadler K, Suehiro J, Osawa T, Oike Y, et al. The calcineurin-NFAT-angiopoietin-2 signaling axis in lung endothelium is critical for the establishment of lung metastases. Cell Rep 2013;4:709-23.
11. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-tran-scriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;2008:102-14.
12. Rana S, Malinowska K, Zoller M. Exosomal tumor microRNA modulates premetastatic organ cells. Neoplasia 2013;15:281-95.
13. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014;25:501-15.
14. Xu Q, Qaum T, Adamis AP. Sensitive blood-retinal barrier breakdown quantitation using Evansblue. InvestOphthalmol VisSci 2001;42:789-94.
15. Obernosterer G, Martinez J, Alenius M. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat Protoc 2007;2: 1508-14.
16. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
17. Liao WT, Ye YP, Zhang NJ, Li TT, Wang SY, Cui YM, et al. MicroRNA-30b functions as a tumour suppressor in human colorectal cancer by targeting KRAS, PIK3CD and BCL2. J Pathol 2014;232:415-27.
18. Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, et al. EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med 2012;18:74-82.
19. Ichikawa T, Sato F, Terasawa K, Tsuchiya S, Toi M, Tsujimoto G, et al. Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells. PLoS One 2012;7:e31422.
20. Gaziel-Sovran A, Segura MF, Di Micco R, Collins MK, Hanniford D, Vega-Saenz de Miera E, et al. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 2011;20:104-18.
21. Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y, et al. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepa-tocellular carcinoma. Hepatology 2010;51:846-56.
22. Zhang J, Zhang H, Liu J, Tu X, Zang Y, Zhu J, et al. miR-30 inhibits TGF-beta1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun 2012;417:1100-5.
23. Chang CC, Zhang QY, Liu Z, Clynes RA, Suciu-Foca N, Vlad G. Down-regulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells. J Immunol 2012;188:3042-52.
24. Yu F, Deng H, Yao H, Liu Q, Su F, Song E. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 2010;29:4194-204.
25. Olaso E, Santisteban A, Bidaurrazaga J, Gressner AM, Rosenbaum J, Vidal-Vanaclocha F. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology 1997;26:634-42.
26. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012; 18:883-91.
27. Balderman JA, Lee HY, Mahoney CE, Handy DE, White K, Annis S, et al. Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30ctopromote vascular smooth muscle cell calcification.JAmHeart Assoc 2012;1:e003905.
28. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, et al. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 2008;40:43-50.
29. Qiao F, Zhang K, Gong P, Wang L, Hu J, Lu S, et al. Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis. Mol Biol Rep 2014;41:5693-700.
30. Lin HK, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, Chan CH, et al. Phosphorylation-dependent regulation of cytosolic localization and onco-genic function of Skp2 by Akt/PKB. Nat Cell Biol 2009;11:420-32.
31. Chan CH, Li CF, Yang WL, Gao Y, Lee SW, Feng Z, et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 2012;149:1098-111.
32. Inuzuka H, Gao D, Finley LW, Yang W, Wan L, Fukushima H, et al. Acetylation-dependent regulation of Skp2 function. Cell 2012;150:179-93.
33. Chan CH, Morrow JK, Li CF, Gao Y, Jin G, Moten A, et al. Pharmacological inactivation ofSkp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 2013;154:556-68.
34. Poudel S, Song J, Jin EJ, Song K. Sulfuretin-induced miR-30C selectively downregulates cyclin D1 and D2 and triggers cell death in human cancer cell lines. Biochem Biophys Res Commun 2013;431:572-8.
35. Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, et al. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is down-regulatedinhepatocellularcarcinoma.EurJSurg Oncol 2014;40:1586-94.
36. Zhang N, Wang X, Huo Q, Sun M, Cai C, Liu Z, et al. MicroRNA-30a suppresses breast tumor growth and metastasis by targeting metadherin. Oncogene 2014;33:3119-28.
37. Zhao JJ, Lin J, Zhu D, Wang X, Brooks D, Chen M, et al. miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the onco-genic Wnt/beta-catenin/BCL9 pathway. Cancer Res 2014;74:1801-13.
38. Kao CJ, Martiniez A, Shi XB, Yang J, Evans CP, Dobi A, et al. miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT. Oncogene 2014;33:2495-503.
39. Joglekar MV, Patil D, Joglekar VM, Rao GV, Reddy DN, Mitnala S, et al. The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets 2009;1:137-47.
40. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28:1721-6.
41. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A 2011;108:522-7.